| Sarcoidosis-like reactions induced by checkpoint inhibitors I Gkiozos, A Kopitopoulou, A Kalkanis, IN Vamvakaris, MA Judson, ... Journal of Thoracic Oncology 13 (8), 1076-1082, 2018 | 164 | 2018 |
| The intercellular cell adhesion molecule-1 (icam-1) in lung cancer: implications for disease progression and prognosis EA Kotteas, P Boulas, I Gkiozos, S Tsagkouli, G Tsoukalas, KN Syrigos Anticancer research 34 (9), 4665-4672, 2014 | 114 | 2014 |
| Carboplatin plus pemetrexed as first-line treatment of patients with malignant pleural mesothelioma: a phase II study N Katirtzoglou, I Gkiozos, N Makrilia, E Tsaroucha, A Rapti, G Stratakos, ... Clinical lung cancer 11 (1), 30-35, 2010 | 94 | 2010 |
| Clinical significance of smoking cessation in subjects with cancer: a 30-year review AN Florou, ICH Gkiozos, SK Tsagouli, KN Souliotis, KN Syrigos Respiratory Care 59 (12), 1924-1936, 2014 | 87 | 2014 |
| Developments in the treatment of non-small cell lung cancer I Gkiozos, A Charpidou, K Syrigos Anticancer Research 27 (4C), 2823-2827, 2007 | 70 | 2007 |
| Therapy-induced toxicity of the lungs: an overview AG Charpidou, I Gkiozos, S Tsimpoukis, D Apostolaki, KD Dilana, ... Anticancer research 29 (2), 631-639, 2009 | 55 | 2009 |
| Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol E Syrigou, I Dannos, E Kotteas, N Makrilia, I Tourkantonis, K Dilana, ... International archives of allergy and immunology 156 (3), 320-324, 2011 | 53 | 2011 |
| Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients EM Karapanagiotou, A Polyzos, KD Dilana, I Gratsias, P Boura, I Gkiozos, ... Lung Cancer 66 (3), 393-398, 2009 | 50 | 2009 |
| Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients EM Karapanagiotou, E Terpos, KD Dilana, C Alamara, I Gkiozos, ... Medical Oncology 27, 332-338, 2010 | 43 | 2010 |
| Histones and lung cancer: Are the histone deacetylases a promising therapeutic target? V Petta, I Gkiozos, A Strimpakos, K Syrigos Cancer chemotherapy and pharmacology 72, 935-952, 2013 | 33 | 2013 |
| Psychological correlates of sleep quality in lung cancer patients under chemotherapy: a single‐center cross‐sectional study D Papadopoulos, M Kiagia, A Charpidou, I Gkiozos, K Syrigos Psycho‐Oncology 28 (9), 1879-1886, 2019 | 29 | 2019 |
| Levels of vascular endothelial growth factor in serum and pleural fluid are independent predictors of survival in advanced non-small cell lung cancer: Results of a prospective … I Gkiozos, S Tsagouli, A Charpidou, D Grapsa, E Kainis, C Gratziou, ... Anticancer Research 35 (2), 1129-1137, 2015 | 27 | 2015 |
| Pleural lavage cytology: where do we stand? L Toufektzian, E Sepsas, V Drossos, I Gkiozos, K Syrigos Lung Cancer 83 (1), 14-22, 2014 | 25 | 2014 |
| Carboplatin-pemetrexed adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): a phase II study EM Karapanagiotou, PG Boura, G Papamichalis, M Konstantinou, ... Anticancer research 29 (10), 4297-4301, 2009 | 23 | 2009 |
| Soluble ICAM-1 levels in small-cell lung cancer: prognostic value for survival and predictive significance for response during chemotherapy EA Kotteas, I Gkiozos, S Tsagkouli, A Bastas, I Ntanos, MW Saif, ... Medical oncology 30, 1-5, 2013 | 22 | 2013 |
| Radiomics/radiogenomics in lung cancer: basic principles and initial clinical results AK Anagnostopoulos, A Gaitanis, I Gkiozos, EI Athanasiadis, ... Cancers 14 (7), 1657, 2022 | 20 | 2022 |
| Malignant superior vena cava syndrome: state of the art V Patriarcheas, M Grammoustianou, N Ptohis, I Thanou, M Kostis, ... Cureus 14 (1), 2022 | 20 | 2022 |
| Lung cancer patients' journey from first symptom to treatment: Results from a Greek registry G Kourlaba, I Gkiozos, E Kokkotou, G Stefanou, A Papaspiliou, K Syrigos Cancer Epidemiology 60, 193-200, 2019 | 20 | 2019 |
| Thymoma and radiation therapy: a systematic review of medical treatment A Giannopoulou, I Gkiozos, KJ Harrington, KN Syrigos Expert review of anticancer therapy 13 (6), 759-766, 2013 | 20 | 2013 |
| Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients A Charpidou, I Gkiozos, M Konstantinou, A Eleftheraki, P Demertzis, ... Cancer letters 304 (2), 144-153, 2011 | 20 | 2011 |
